Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

13

Revenue 2017

Bristol-Myers Squibb

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Bristol-Myers Squibb's 2013 sales performance.

Bristol-Myers Squibb

Innate Pharma and AstraZeneca take monalizumab into phase 3

Innate Pharma and AstraZeneca take monalizumab into phase 3 AZ has been seeking Imfinzi combinations which could help it gain on earlier-to-market rivals in the checkpoint inhibitor category, including Merck &Co’s Keytruda and Bristol-Myers Squibb’s

France’s Innate Pharma eyes $100m Nasdaq IPO

France’s Innate Pharma eyes $100m Nasdaq IPO Bristol-Myers Squibb's Opdivo, but its first efforts – centred on CTLA4 inhibitor tremelimumab – have ended in failure.

Breath test could predict response to immunotherapy

Breath test could predict response to immunotherapy Although checkpoint inhibitors, including PD-1/PD-L1 blockbusters Keytruda (pembrolizumab) from MSD and Opdivo (nivolumab) from Bristol-Myers Squibb, have improved survival in various cancer areas, most patients do not

Encouraging signs in biomarker R&D

Encouraging signs in biomarker R&D In June 2018, Bristol Myers-Squibb sought approval for Opdivo and low-dose Yervoy in lung cancer in patients with a TMB of greater than ten mutations per megabase.

AbbVie/Allergan's merger faces public opposition

AbbVie/Allergan's merger faces public opposition Potential push-back from the FTC could create problems however, especially in light of the regulatory difficulties experienced by Bristol-Myers Squibb in its $73bn takeover of Celgene.

[ Previous 5 results ] 2 3 4 5 6 7 8 9 10 11 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Makara Health

Independent healthcare communications agency with a passion to develop inspirational ideas that create sustained and positive change. Whether it is...

Latest intelligence

Pharma index map
The 2019 CPhI Pharma Index Report
Examining this year’s industry performance...
Five key trends in precision and personalised healthcare
Here, we deep dive into five of the key trends in precision medicine and personalised healthcare to explore how the healthcare industry is changing and how pharmaceutical and biotech companies...
OPEN Health Graduate Programme: from OPEN VIE to OPEN Health Medical Communications
Isobel Owens shares her experience of the OPEN Health Graduate Programme from OPEN VIE to OPEN Health Medical Communications...

Infographics